Current status and prospect of tracer technology in gastric cancer

SHEN Xiaofei, GUAN Wenxian 

Abstract:  “It is unfortunate for gastric cancer patients to get sick, but it is fortunate if they can receive reasonable and standardized treatment.” Surgery, as the core strategy in the treatment of gastric cancer, is the main approach to achieving reasonable and standardized treatment ...

Chin J Clin Res,2025,38(1): 1-5. [PDF]

• Research progress of hepatocyte nuclear factor 4α in gastric cancer and precancerous lesions

  YANG Yuyan, ZHAO Weihan, WANG Siyu, DONG Siqi

  Chin J Clin Res,2025,38(1):6-10. [PDF]
  

• Expression and effect of P38 mitogen-activated protein kinase and transforming growth factor-β in

  gastric cancer

  YANG Lu, LI Zixin, CHANG Jianlan

  Chin J Clin Res,2025,38(1):11-15.  [PDF]

• Efficacy and safety of endoscopic submucosal dissection in the treatment of early cardia cancer and

  non-cardia cancer with submucosal infiltration

  ZHU Tingting, REN Ximei, YANG Jinping, LI Wenjun, XIANG Ying , XU Guifang

  Chin J Clin Res,2025,38(1):16-21. [PDF]

• Clinical effect of endoscopic submucosal dissection in the treatment of Siewert type Ⅱ early adenocarcinoma

  and precancerous lesions of esophagogastric junction

  GUO Huiwen, HE Qibin, LIU Yang, TIE Guangxuan, CHEN Yijia 

  Chin J Clin Res,2025,38(1):22-27.  [PDF]

  
  

• Efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer

  GUO Mengya, CHEN Yue, PENG Weiwei, SHA Huanhuan, FANG Ying, ZHOU Guoren 

  Chin J Clin Res,2025,38(1):28-32.  [PDF]

• Short-term efficacy and safety of sintilimab combined with oxaliplatin and capecitabine as neoadjuvant

  therapy for locally advanced gastric cancer

  ZHANG Shuai, LIU Liangliang, HUANG Di, SHENG Ru, DU Xuetao, LI Shuguang, HU Nan, ZHAO Yifeng 

  Chin J Clin Res,2025,38(1):33-36,41.  [PDF]

  
  

• Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for

  HER2-negative advanced gastric cancer

  ZHANG Xiaorui, SHAN Haixia, ZHU Zhengqiu 

  Chin J Clin Res,2025,38(1):37-41.   [PDF]

• Clinical efficacy and safety of PD-1 inhibitor combined with apatinib in the third line treatment of

  HER2-negative advanced gastric cancer

  XU Hongmei, CHEN Lanlan, ZHOU Tao, GAO Liming 

  Chin J Clin Res,2025,38(1):42-47. [PDF]

• Influencing factors of lymph node metastasis and construction of a nomogram prediction model in elderly

  patients with early gastric cancer

  LIANG Yufei, LI Chunying, ZOU Han, TIAN Liang, LI Xinmeng 

  Chin J Clin Res,2025,38(1):48-52. [PDF]

• Predictive value of prealbumin combined with neutrophil-to-lymphocyte ratio in early postoperative

  complications of gastric cancer

  GUO Maosen, LI Hu, GAO Fei, HAN Bin 

  Chin J Clin Res,2025,38(1):53-56.  [PDF]

• Prognostic value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in

  patients with gastric cancer

  ZHANG Le, LI Wei, HUANG Zeping, WANG Wenjie, CHEN Xiao 

  Chin J Clin Res,2025,38(1):57-61,66. [PDF]

• Analysis of risk factors of acute respiratory failure after radical resection of esophageal cancer by two

  methods

  LEI Xiuwen, ZHU Xiaolei, TIAN Long 

  Chin J Clin Res,2025,38(1):62-66. [PDF]

• Diagnostic value of three evaluation systems for medium-to-high risk carcinogenesis in chronic atrophic

  gastritis

  CAO Yanli, PAN Hongnian, LIU Xiaoyan, WANG Xiuzhong 

  Chin J Clin Res,2025,38(1):67-71.  [PDF]

• Expression and clinical significance of IGFBP7 and TGFβ1 in esophageal squamous cell carcinoma

  REN Huaijing, MA Zhenqi, WANG Xuehong, TAO Jianan

  Chin J Clin Res,2025,38(1):72-76.  [PDF]

• Effect of Porphyromonas gingivalis up-regulating Src protein expression on proliferation, migration and

  invasion of esophageal squamous cell carcinoma

  GUO Yijun, GAO Shegan, SHI Linlin 

  Chin J Clin Res,2025,38(1):77-81.  [PDF]

• Relationship between puerarin and urothelial carcinoembryonic antigen 1 expression in apoptosis and

  autophagy of esophageal cancer cells

  LI Jing, WANG Jumei, TIAN Jingrong, BI Lihua, GAO Yuanyuan, SHANG Hong 

  Chin J Clin Res,2025,38(1):82-86.  [PDF]